Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04086433 · ClinicalTrials.gov registry record
Gastric Tissue Stapler Comparison Study
A clinical trial of Gastric Resection, sponsored by Standard Bariatrics.
- Completed
- Registry status
- 36
- Enrollment target
- 1
- Study location
NCT04086433 is a study of Gastric Resection that has completed, run by Standard Bariatrics. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04086433, a study of Gastric Resection, has completed, sponsored by Standard Bariatrics.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is conducted to compare performance characteristics of staple lines resecting the stomach in excised human gastric tissue with existing Echelon Flex Powered Plus GST System (Ethicon, size: 60mm, "Echelon") stapler and the Titan SGS (Standard Bariatrics, "Titan"). The Study is a single center clinical trial, randomized (1:1, Arm A - Ethicon Echelon 60 application, Arm B - Standard Bariatrics Titan SGS application) which utilizes the excised stomach tissue from up to 75 adults undergoing laparoscopic sleeve gastrectomy (LSG). This study will be conducted in the USA.
Conditions Studied
Interventions
- DEVICE gastric tissue resection
Study Locations (1)
New York
- University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2019-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04086433
The ClinicalTrials.gov registry entry for NCT04086433 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Standard Bariatrics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastric Resection appearing as the primary indexed condition, and to 1 intervention - of which gastric tissue resection is the first listed.
NCT04086433 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04086433 about?
NCT04086433 is a clinical study titled "Gastric Tissue Stapler Comparison Study". This study is conducted to compare performance characteristics of staple lines resecting the stomach in excised human gastric tissue with existing Echelon Flex Powered Plus GST System (Ethicon, size: 60mm, "Echelon") stapler and the Titan SGS (Standard Bariatrics, "Titan"). The Study is a single ce...
What is the current status of trial NCT04086433?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2019-07-15. Estimated completion is 2019-10-30.
What conditions does trial NCT04086433 study?
This clinical trial studies the following conditions: Gastric Resection.
What interventions are being tested in trial NCT04086433?
The interventions under investigation include: gastric tissue resection (DEVICE).
Who is sponsoring clinical trial NCT04086433?
This trial is sponsored by Standard Bariatrics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04086433 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.